Health Condition 1: null- urological diseases, gynaecological diseases
Conditions
Interventions
Intervention1: Mannitol at the dose of 0.5g/kg single dose: Mannitol has been well documented as one of the therapies in reducing ICP. Mannitol has been used in different doses in controlling rise in
Sponsors
POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH CHANDIGARH
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age above18 years 2. ASA class I-III 3. Urological patients undergoing robotic assisted surgeries 4. Gastrointestinal patients undergoing robotic assisted surgeries 5. Gynecological patients undergoing robotic assisted surgeries
Exclusion criteria
Exclusion criteria: 1. ASA class IV and above 2. Patients with a history of glaucoma. 3. Patients with corneal disease, retinal vascular disease 4. Patients with known cerebrovascular disease 5. Patients with known renal disease 6. Patient not giving consent 7. Patient having known allergy to any drug. 8. Pregnant patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To find out the effects of using different doses of mannitol on ICP in patients undergoing robotic assisted abdominal surgery in steep Tredelendburg position.Timepoint: T1 before surgery in supine position after induction(10 mins postracheal Intubation) â?¢ T2 After Tredelendburg position â?¢ T4,5,6â?¦ every 30 mins â?¢ Tdedock After dedocking â?¢ Tsupine After patient is made supine | — |
Secondary
| Measure | Time frame |
|---|---|
| To find out the effects of the following factors in managing the rise in ICP and facial edema (i) Duration of surgery (ii) Total I.V. fluid infused during surgery Timepoint: End of surgery | — |
Countries
India
Contacts
Public ContactDr Kamal Kajal
MD,PDCC
Outcome results
None listed